PROGNOSIS AFTER BREAST CANCER DIAGNOSIS IN WOMEN EXPOSED TO ESTROGEN AND ESTROGEN-PROGESTOGEN REPLACEMENT THERAPY
The DOI matches its Crossref record.
Abstract
The association between survival in breast cancer and menopausal hormone treatment prior to diagnosis was analyzed by comparing 261 women who developed the disease in a population-based cohort of estrogen-treated women with 6,617 breast cancer patients without any recorded estrogen treatment drawn from the same population. Complete follow-up was achieved during the 0-9 years of observation. The relative survival rate was significantly higher (p = 0.02), by about 10 percentage points at eight years, in patients who had received estrogen treatment--corresponding to an approximately 40% reduction in excess mortality. The more favorable course could be confirmed only in patients aged 50 years or more at diagnosis (p less than 0.01) and was most pronounced in recent users, that is, in women whose treatment was ongoing (p less than 0.01) or had been discontinued within one year prior to diagnosis. The time from first use to diagnosis and the total duration of estrogen medication were virtually unrelated to survival when the effect of recency was taken into account in multivariate analyses. The authors were unable to examine the effect of stage at diagnosis on the results. Several factors, particularly selection bias and surveillance bias, might have affected the results in favor of the women receiving hormone replacement therapy, but there is a possibility that exogenous female sex hormones affect survival in women with breast cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Kanis, J. A., & Kanis, J. A. (1994) · Osteoporosis International · doi:10.1007/bf01622200 · Cited by 2,516
Osborne, C. K., Bardou, V., Hopp, T. A., Chamness, G. C., Hilsenbeck, S. G., Fuqua, S. A. W., Wong, J., Allred, D. C., Clark, G. M., & Schiff, R. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.5.353 · Cited by 786
The Prevention and Treatment of Osteoporosis
Wood, A. J. J., Riggs, B. L., & Melton, L. J. (1992) · New England Journal of Medicine · doi:10.1056/nejm199208273270908 · Cited by 754
Decreased Mortality in Users of Estrogen Replacement Therapy
Henderson, B. E. (1991) · Archives of Internal Medicine · doi:10.1001/archinte.1991.00400010095012 · Cited by 632
Relationship Between Estrogen Levels, Use of Hormone Replacement Therapy, and Breast Cancer
Colditz, G. A. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.11.814 · Cited by 399
Metadata
- Authors
- BERGKVIST, L., ADAMI, H.-O., PERSSON, I., BERGSTROM, R., & KRUSEMO, B. U.
- Venue
- American Journal of Epidemiology
- Publisher
- Oxford University Press (OUP)
- Published
- 1989-08
- Volume
- 130
- Issue
- 2
- Pages
- 221-228
- ISSN
- 0002-9262 (ISSN-L)
- 1476-6256
- OpenAlex
- W2289353246
- Cited by
- 240
- References
- 0
- FWCI
- 9.28
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: PROGNOSIS AFTER BREAST CANCER DIAGNOSIS IN WOMEN EXPOSED TO ESTROGEN AND ESTROGEN-PROGESTOGEN REPLACEMENT THERAPY. https://app.cochat.ai/papers/10.1093/oxfordjournals.aje.a115328
- The paper
- BERGKVIST, L., ADAMI, H.-O., PERSSON, I., BERGSTROM, R., & KRUSEMO, B. U. (1989). PROGNOSIS AFTER BREAST CANCER DIAGNOSIS IN WOMEN EXPOSED TO ESTROGEN AND ESTROGEN-PROGESTOGEN REPLACEMENT THERAPY. American Journal of Epidemiology. https://doi.org/10.1093/oxfordjournals.aje.a115328
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.